Trademark: 79343310
Word
POWERED BY PARSORTIX
Status Date
Tuesday, April 9, 2024
Filing Date
Thursday, March 24, 2022
Published for Opposition
Tuesday, April 9, 2024
9 Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology, namely, specimen collection and handling vials, pipettes, burettes, dispensing bottles for laboratory reagents, microplates and assay plates in the nature of test tubes, sample test tubes; Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology, namely, DNA analysis apparatus for laboratory use, apparatus for analysing genes for laboratory use; laboratory apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; cell analyzer in the nature of flow cytometers and flow-based analyzers providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analysing blood not for medical use, and all for laboratory use, diagnostic or general research use, namely, sample test tubes, vials, disposable dispenser syringes, pipettes, dispensing bottles for laboratory reagents, microplates and assay plates in the nature of test tubes; parts and fittings for the aforesaid goods, namely medical laboratory research instruments for use in the detection of cancer
5 Diagnostic medical reagents and assay components for testing of body fluids, including blood and plasma, and cells; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical use; all the foregoing not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnostics
1 Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, science and medical research; buffer solutions and reagents for use with laboratory apparatus, namely, buffer solutions and reagents for scientific and research use for use with separation apparatus and analysis apparatus; diagnostic biomarkers, namely, nucleic acids, proteins and other biochemical ligands all of the foregoing being diagnostic preparations for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for scientific and clinical research
10 Medical apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases, namely, medical diagnostic apparatus for testing DNA and RNA samples and medical diagnostic testing instruments for processing and analysis of genetic samples using gene expression tests, gene expression profiling assays and protein biomarkers; medical testing apparatus, equipment and instruments for testing body fluids, blood and plasma, cancer cells, and foetal cells; parts and fittings for the aforesaid goods, namely, diagnostic apparatus, equipment and instruments for cytology, histology and for use in detecting cancer
Apr 9, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 9, 2024
Published For Opposition
Apr 8, 2024
Notification Processed By Ib
Mar 20, 2024
Notification Of Notice Of Publication E-Mailed
Mar 20, 2024
Notification Of Possible Opposition Sent To Ib
Mar 20, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 4, 2024
Approved For Pub - Principal Register
Feb 29, 2024
Examiner's Amendment Entered
Feb 29, 2024
Notification Of Examiners Amendment E-Mailed
Feb 29, 2024
Examiners Amendment E-Mailed
Feb 29, 2024
Examiners Amendment -Written
Jan 31, 2024
Teas/Email Correspondence Entered
Jan 31, 2024
Correspondence Received In Law Office
Jan 31, 2024
Teas Request For Reconsideration Received
Dec 18, 2023
Notification Of Possible Opposition - Processed By Ib
Nov 29, 2023
Notification Of Possible Opposition Sent To Ib
Nov 29, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Aug 4, 2023
Notification Of Final Refusal Emailed
Aug 4, 2023
Final Refusal E-Mailed
Aug 4, 2023
Final Refusal Written
Jul 3, 2023
Assigned To Examiner
Jun 7, 2023
Teas/Email Correspondence Entered
Jun 6, 2023
Correspondence Received In Law Office
Jun 6, 2023
Teas Response To Office Action Received
Apr 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 27, 2023
Teas Change Of Correspondence Received
Apr 27, 2023
Teas Change Of Domestic Representatives Address
Apr 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 27, 2023
Teas Change Of Owner Address Received
Jan 5, 2023
Refusal Processed By Ib
Dec 10, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Dec 9, 2022
Refusal Processed By Mpu
Sep 29, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Sep 28, 2022
Non-Final Action Written
Sep 26, 2022
Assigned To Examiner
Jun 28, 2022
Application Filing Receipt Mailed
Jun 24, 2022
New Application Office Supplied Data Entered
Jun 23, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
